Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · IEX Real-Time Price · USD
41.47
+0.08 (0.19%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Dyne Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Dyne Therapeutics stock have an average target of 42.56, with a low estimate of 29 and a high estimate of 56. The average target predicts an increase of 2.63% from the current stock price of 41.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DYN stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 3 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $39 → $43 | Buy | Maintains | $39 → $43 | +3.69% | Jul 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $31 → $42 | Strong Buy | Maintains | $31 → $42 | +1.28% | May 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $46 → $48 | Strong Buy | Maintains | $46 → $48 | +15.75% | May 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | -25.25% | May 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $47 | Buy | Reiterates | $47 | +13.33% | May 6, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
16.70M
EPS This Year
-3.06
from -3.95
EPS Next Year
-3.06
from -3.06
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 133.8M | 306.1M | 465.2M | 722.2M |
| Avg | n/a | 16.7M | 55.1M | 200.1M | 650.3M |
| Low | n/a | n/a | n/a | n/a | 582.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 1,732.8% | 744.6% | 260.9% |
| Avg | - | - | 229.8% | 263.3% | 224.9% |
| Low | - | - | - | - | 190.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.76 | -1.48 | 0.24 | 1.47 | 3.12 |
| Avg | -3.06 | -3.06 | -2.75 | -1.21 | 1.48 |
| Low | -3.73 | -3.91 | -3.97 | -2.48 | -0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.